Management of Bifurcation Culprit Lesion in the Setting of Anterior ST Elevation Myocardial Infarction

Ahmed Mahmoud El Amrawy *

Cardiology Department, Faculty of Medicine, Alexandria University, Egypt.

Abdelrahman Ramadan Assal

Cardiology Department, Faculty of Medicine, Alexandria University, Egypt.

Amr Mahmoud Zaki

Cardiology Department, Faculty of Medicine, Alexandria University, Egypt.

Salah Mohamed Eltahan

Cardiology Department, Faculty of Medicine, Alexandria University, Egypt.

*Author to whom correspondence should be addressed.


Introduction: Coronary bifurcation lesions are considered one of the challenging entities in the field of coronary intervention due to the risk of side branch loss and higher risk of stent thrombosis. However, there is limited data about the proper management of such lesions in the setting of myocardial infarction as most bifurcation lesion studies excluded patients with acute coronary syndromes (ACS). The aim of this study was to compare in-hospital and mid-term outcomes of single-stent and two-stents strategy in the management of bifurcation culprit lesions in patients presenting with anterior STEMI.

Methods: This retrospective multi-center study included all patients presented with anterior STEMI who underwent primary PCI between January 2017 and December 2019, coronary angiography showed true bifurcation lesion with sizable side branch that can be managed by stenting. Patients with left main bifurcation, those indicated for urgent CABG, and patients in cardiogenic shock were excluded. Included patients were divided into two groups according to the stenting strategy either single or two stents. Six months follow up data were collected by telephone calls and by examination of medical records.

Results: Out of 1355 anterior STEMI patients presented between January 2017 and December 2019, 158 patients (11.6%) were identified to have bifurcation culprit lesions with a sizable diagonal branch. 93 patients (59%) were treated by single stent while 65 patients (41%) were managed by two-stents strategy. The baseline characteristics and angiographic findings were similar in both groups except for higher side branch involvement in the two stents group (83.31%±11.20 vs 71.88%±15.05, t= -5.39, p <0.001). Mean fluoroscopy time (23.96±8.90 vs 17.81±5.72 mins) and contrast volume (259.23± 59.45 vs 232.58± 96.18 ml) were significantly higher in two stents group than single stent group (p=0.049). However, the angiographic success rates (residual stenosis ≤30% and restoration of TIMI flow grade II or III) were comparable (96.8% vs 99%, MCp=0.151). There is no significant difference in the overall incidence rate of MACE in both groups 6 months following the index procedure (13.9 % vs 16.9%, FEp=0.698), with no difference between different bifurcation stenting techniques in patients managed with two stents.

Conclusion: Although two stents strategy in the setting of STEMI is much complex with more fluoroscopy time and contrast volume, the procedural success rate and the incidence of MACE were comparable to one stent strategy, on medium-term follow up.

Keywords: Coronary artery disease, ST segment elevation myocardial infarction, primary percutaneous coronary intervention, bifurcation lesions

How to Cite

Amrawy , A. M. E., Assal , A. R., Zaki, A. M., & Eltahan , S. M. (2023). Management of Bifurcation Culprit Lesion in the Setting of Anterior ST Elevation Myocardial Infarction. Cardiology and Angiology: An International Journal, 12(4), 6–20.


Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31(8):943-57.

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation. 2017;135(10): e146-e603.

Xu B, Redfors B, Yang Y, Qiao S, Wu Y, Chen J, et al. Impact of operator experience and volume on outcomes after left main coronary artery percutaneous coronary intervention. JACC Cardiovasc Interv. 2016;9(20):2086-93.

Janssens GN, van der Hoeven NW, Lemkes JS, Everaars H, van de Ven PM, Marques KMJ, et al. 1-Year outcomes of delayed versus immediate intervention in patients with transient ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2019;12(22):2272-82.

Lassen JF, Burzotta F, Banning AP, Lefèvre T, Darremont O, Hildick-Smith D, et al. Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club. EuroIntervention. 2018;13(13):1540-53.

Kumsars I, Holm NR, Niemelä M, Erglis A, Kervinen K, Christiansen EH, et al. Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: The Nordic-Baltic Bifurcation Study IV. Open Heart. 2020;7(1):e000947.

Banning AP, Lassen JF, Burzotta F, Lefèvre T, Darremont O, Hildick-Smith D, et al. Percutaneous coronary intervention for obstructive bifurcation lesions: The 14th consensus document from the European Bifurcation Club. EuroIntervention. 2019; 15(1):90-8.

Ibanez B, James S. The 2017 ESC STEMI guidelines. Eur Heart J. 2018;39(2):79-82.

Franchi F, Rollini F, Angiolillo DJ. Antithrombotic therapy for patients with STEMI undergoing primary PCI. Nat Rev Cardiol. 2017;14(6):361-79.

Erglis A. Lessons for the treatment of bifurcation lesions: From nowadays to the future. Int Cardiol. 2011;3(1):55.

Frangos C, Noble S, Piazza N, Asgar A, Fortier A, Ly QH, et al. Impact of bifurcation lesions on angiographic characteristics and procedural success in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Arch Cardiovasc Dis. 2011;104(4):234-41.

Raphael CE, O'Kane PD. Contemporary approaches to bifurcation stenting. JRSM Cardiovasc Dis. 2021;10: 2048004021992190.

Field A. Discovering statistics using IBM SPSS statistics. Sage; 2013.

SPSS I. IBM SPSS statistics version 21. Boston, Mass: International Business Machines Corp; 2012.

Pan M, Ojeda S. Bifurcation lesions causing an STEMI. Are they a different animal? Rev Esp Cardiol (Engl Ed). 2018; 71(10):779-81.

Salinas P, Mejía-Rentería H, Herrera-Nogueira R, Jiménez-Quevedo P, Nombela-Franco L, Núñez-Gil IJ, et al. Bifurcation culprit lesions in ST-segment elevation myocardial infarction: Procedural success and 5-year outcome compared with nonbifurcation lesions. Rev Esp Cardiol (Engl Ed). 2018;71(10):801-10.

Abdel-Hakim DE, Garot P, Champagne S, Maklady F, el-Hawary A, Dubois-Randé JL, et al. Impact of bifurcation lesions on clinical outcome and prognosis of primary angioplasty in acute myocardial infarction. EuroIntervention. 2008;4(1):93-8.

Dudek D, Mehran R, Dziewierz A, Brener SJ, Rakowski T, Brzezinski M, et al. Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). EuroIntervention. 2013;9(7):817-23.

Choi KH, Song YB, Jeong JO, Park TK, Lee JM, Yang JH, et al. Treatment strategy for STEMI with bifurcation culprit lesion undergoing primary PCI: The COBIS II registry. Rev Esp Cardiol (Engl Ed). 2018;71(10):811-9.

Kwan TW, Gujja K, Liou MC, Huang Y, Wong S, Coppola J, et al. Bifurcation stenting in patients with ST-segment elevation myocardial infarction: an analysis from dkcrush II randomized study. Catheter Cardiovasc Interv. 2013;82(3): E133-7.

Yurtdaş M, Asoğlu R, Özdemir M, Asoğlu E. An upfront two-stent strategy for true coronary bifurcation lesions with A large side branch in acute coronary syndrome: A two-year follow-up study. Medicina (Kaunas). 2020;56(3):102.